San Diego, CA -- (SBWIRE) -- 12/16/2015 -- A deadline is coming up on December 22, 2015 in the settlement reached in the securities class action lawsuit filed for shareholders who purchased shares of Invacare Corporation (NYSE: IVC) between February 27, 2009, and December 7, 2011.

Investors who purchased a significant amount of shares of Invacare Corporation (NYSE: IVC) between February 27, 2009, and December 7, 2011, have certain options and should contact the Shareholders Foundation by email at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The settlement proof of claim form or detailed settlement notice for the settlement in the Invacare Corporation (NYSE: IVC) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/invacare-corporation-nyse-ivc-investor-securities-class-action-lawsuit-05242013

In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is December 22, 2015. The class action administrator for this case is Garden City Group, LLC.

The lawsuit was originally filed in the U.S. District Court for the Northern District of Ohio over alleged violations of Federal Securities Laws by Invacare Corporation in connection with certain allegedly false and misleading statements made between July 22, 2010 and December 7, 2011.

According to the complaint the plaintiff alleges for shareholders in Invacare Corporation (NYSE: IVC) common stock during the period of July 22, 2010 through December 7, 2011, that Invacare Corporation and certain of its senior executives violated provisions of the Securities Exchange Act of 1934 by issuing allegedly false and misleading press releases, financial statements, filings with the Securities and Exchange Commission ("SEC"), and statements during investor conference calls. More specifically, the plaintiff alleges that Invacare Corporation and certain of its senior executives misled investors regarding Invacare Corporation's noncompliance with Food and Drug Administration ("FDA") guidelines and Current Good Manufacturing Practices ("CGMP"), and masked the fact that the Company suffered from widespread operational, quality, and regulatory deficiencies.

The plaintiff claims that Invacare Corporation allegedly concealed from investors that it received a series of warnings from the FDA -- known as Forms 483 -- which identified serious compliance violations at its two major United States-based manufacturing facilities.

The plaintiff alleges that over the next several months, Defendants allegedly continued to downplay the scope and significance of Invacare Corporation's compliance issues, despite its receipt of two additional Forms 483 in August 2011, which were allegedly concealed from investors.

Those who purchased shares of Invacare Corporation (NYSE: IVC) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com